Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
ACS Medicinal Chemistry Letters|July 18, 2019
Permeability of Cyclic Peptide Macrocycles and Cyclotides and Their Potential as TherapeuticsSpiros Liras, Kim F Mcclure
Organic Letters|June 25, 2013
Enantioselective hydroarylation of bridged [3.2.1] heterocycles: an efficient entry into the homoepibatidine skeletonRyan A Brawn, Cristiano R W Guimarães, Kim F McClure, et al.
Organic Letters|September 8, 2012
An efficient synthesis of bridged heterocycles from an Ir(I) bis-amination/ring-closing metathesis sequenceRyan A Brawn, Cristiano R W Guimarães, Kim F McClure, et al.
Bioorganic & Medicinal Chemistry Letters|February 28, 2009
Biochemical basis for differences in metabolism-dependent genotoxicity by two diazinylpiperazine-based 5-HT2C receptor agonistsAmit S Kalgutkar, Jonathan N Bauman, Kim F McClure, et al.
Nature Structural & Molecular Biology|June 5, 2019
Structural basis for selective stalling of human ribosome nascent chain complexes by a drug-like moleculeWenfei Li, Fred R Ward, Kim F McClure, et al.
Chemical Research in Toxicology|September 24, 2011
Oxidative metabolism of a quinoxaline derivative by xanthine oxidase in rodent plasmaRaman Sharma, Heather Eng, Gregory S Walker, et al.
Bioorganic & Medicinal Chemistry Letters|December 9, 2009
Continued exploration of the triazolopyridine scaffold as a platform for p38 MAP kinase inhibitionKevin D Jerome, Paul V Rucker, Li Xing, et al.
Bioorganic & Medicinal Chemistry Letters|November 29, 2018
Discovery of N-(piperidin-3-yl)-N-(pyridin-2-yl)piperidine/piperazine-1-carboxamides as small molecule inhibitors of PCSK9Allyn T Londregan, Gary Aspnes, Chris Limberakis, et al.
ACS Central Science|October 28, 2024
Activity-Based DNA-Encoded Library Screening for Selective Inhibitors of Eukaryotic TranslationHuda Barhoosh, Anjali Dixit, Wesley G Cochrane, et al.
Biopharmaceutics & Drug Disposition|September 1, 2006
Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomesAmit S Kalgutkar, Heather L Hatch, Frederick Kosea, et al.
Pageof 4